sii’s
DCGI approves market authorisation for SII’s Covid vaccine Covovax as heterologous booster dose-
By PTI NEW DELHI: The Drug Controller General of India (DCGI) has approved market authorisation to COVID-19 vaccine Covovax as ...
Government panel recommends emergency approval for SII’s Covovax for 7-11 year olds-
By PTI NEW DELHI: An expert panel of India’s central drug authority on Friday recommended granting emergency use authorisation to ...
Government panel recommends market authorisation for SII’s qHPV vaccine against cervical cancer-
By PTI NEW DELHI: An expert panel of India’s central drug authority on Wednesday recommended granting of market authorisation to ...
SII’s COVID vaccine Covovax now available for 12-17 age group at private centres-
By PTI NEW DELHI: Children aged 12 to 17 years can now get the Serum Institute’s coronavirus vaccine Covovax at ...
DCGI’s EUA nod to SII’s Covovax for 12-17 years age group-
By PTI NEW DELHI: India’s drug regulator has granted restricted emergency use authorisation to Serum Institute’s COVID-19 vaccine Covovax for ...
DGCI gives nod to SII’s proposal to manufacture vaccine against omicron for test, analysis-
By PTI NEW DELHI: The Drugs Controller General of India (DCGI) has approved Serum Institute of India’s proposal to manufacture ...
